Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 65 years of age or older
- People who have multiple myeloma that has come back after treatment or has stopped responding to treatment
- People whose condition makes them suitable for a type of treatment called CAR-T cell therapy or bispecific antibody therapy, as determined by their treating doctor
Who may not be able to join:
- People who are under 65 years of age
- People who currently have an active cancer other than multiple myeloma
- People who have an active condition called AL amyloidosis (a disease where abnormal proteins build up in organs)
- People whose myeloma has spread to or is affecting the brain or spinal cord (central nervous system)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +32497840746
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of ≥VGPR or better according to IMWG criteria at 3 months.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.